TrialMetabolism: clinical and experimental2022

ABCC1 modulates negative feedback control of the hypothalamic-pituitary-adrenal axis in vivo in humans.

Catriona J Kyle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.